Benz E J, Huang S C
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Trans Am Clin Climatol Assoc. 1997;108:78-95.
Regulated alternative pre-mRNA splicing is neither as widely appreciated as a fundamental aspect of controlled gene expression nor as thoroughly studied as transcriptional regulation. However, as exemplified by the phenomena cited in this review, alternative splicing is a fundamentally important mechanism used in the eukaryotic world to enhance the range, versatility and plasticity of the structural information contained within a gene, and to create additional strategies by which the net quantitative output of a given gene product can be controlled. Regulation of RNA splicing gives genes a modularity that adds flexibility, and, therefore, selective advantage, to eukaryotes. It is likely, though unproven, that this opportunity for refined regulation and diversification provides at least one basis for the existence of the tandem exon-intron-exon structure found in the vast majority of eukaryotic genes and many viral genes. Many examples of alternative splicing are known, but, for the majority, no obvious biological impact of the alternatively spliced proteins on known cellular functions can be appreciated. Examples by which selectively regulated splicing pathways alter both the physiology and pathology of a major cellular event, such as differentiation and mechanical function of the red cell membrane, are thus relatively rare. The protein 4.1 gene and mRNA products thus provide an instructive and unusual system in which to explore the broader issue of the role of these regulatory mechanisms in the overall scheme of gene regulation and adaptation. The fact that hereditary hemolytic anemias result from mutations that directly or indirectly disrupt the splicing system emphasized the relevance of these mechanisms to molecular medicine. The features of splicing that we have reviewed in this paper, and the specific impact that regulated splicing exerts on differentiating red cells have, we hope, convinced the reader that RNA splicing is an important, fascinating, and potentially fruitful area for future study of human disease processes.
可变前体mRNA剪接作为基因表达调控的一个基本方面,既没有得到广泛认可,也没有像转录调控那样得到深入研究。然而,正如本综述中所引用的现象所表明的那样,可变剪接是真核生物中一种根本重要的机制,用于增加基因中所含结构信息的范围、多功能性和可塑性,并创造额外的策略来控制给定基因产物的净定量输出。RNA剪接的调控赋予基因一种模块化特性,为真核生物增加了灵活性,进而带来选择性优势。虽然未经证实,但这种精细调控和多样化的机会很可能为绝大多数真核基因和许多病毒基因中存在的串联外显子-内含子-外显子结构的存在提供了至少一个基础。可变剪接的例子很多,但对于大多数情况来说,可变剪接产生的蛋白质对已知细胞功能没有明显的生物学影响。因此,选择性调控的剪接途径改变主要细胞事件(如红细胞膜的分化和机械功能)的生理学和病理学的例子相对较少。蛋白质4.1基因及其mRNA产物因此提供了一个具有启发性且不同寻常的系统,可用于探索这些调控机制在基因调控和适应的整体框架中的更广泛作用。遗传性溶血性贫血是由直接或间接破坏剪接系统的突变引起的,这一事实强调了这些机制与分子医学的相关性。我们在本文中综述的剪接特征,以及调控剪接对分化红细胞的具体影响,希望能使读者相信,RNA剪接是人类疾病过程未来研究的一个重要、迷人且可能富有成果的领域。